Cancer_Statistic_2009_Slides

+ -Text Size

Cancer Statistics 2009

A Presentation From the

American Cancer Society

�2009, American Cancer Society, Inc.

2009 Estimated US Cancer Deaths*

Lung & bronchus 30%

Prostate 9%

Colon & rectum 9%

Pancreas 6%

Leukemia 4%

Liver & intrahepatic 4%
bile duct

Esophagus 4%

Urinary bladder 3%

Non-Hodgkin 3% lymphoma

Kidney & renal pelvis 3%

All other sites 25%

Men
292,540

Women
269,800

26% Lung & bronchus

15% Breast

9% Colon & rectum

6% Pancreas

5% Ovary

4% Non-Hodgkin
lymphoma

3% Leukemia

3% Uterine corpus

2% Liver & intrahepatic bile duct

2% Brain/ONS

25% All other sites

ONS=Other nervous system.

Source: American Cancer Society, 2009.

US Mortality, 2006

Rank

Cause of Death

No. of deaths

% of all deaths

*Includes nephrotic syndrome and nephrosis.

Source: US Mortality Data 2006, National Center for Health Statistics, Centers for Disease Control and Prevention, 2009.

1. Heart Diseases 631,636 26.0

2. Cancer 559,888 23.1

3. Cerebrovascular diseases 137,119 5.7

4. Chronic lower respiratory diseases 124,583 5.1

5. Accidents (unintentional injuries) 121,599 5.0

6. Diabetes mellitus 72,449 3.0

7. Alzheimer disease 72,432 3.0

8. Influenza & pneumonia 56,326 2.3

� Nephritis* 45,344 1.9

10. Septicemia 34,234 1.4

Change in US Death Rates* from 1991 to 2006

Rate Per 100,000

1991

2006

* Age-adjusted to 2000 US standard population.

Sources: US Mortality Data, National Center for Health Statistics, Centers for Disease Control and Prevention, 2009.

Trends in the Number of Cancer Deaths Among Men and Women, US, 1930-2006

Men

Women

Number of Cancer Deaths

Source: US Mortality Data, 1930-2006, National Center for Health Statistics, Centers for Disease

Control and Prevention, 2009.

Cancer Death Rates* by Sex, US, 1975-2005

Rate Per 100,000

Men

Both Sexes

Women

*Age-adjusted to the 2000 US standard population.

Source: US Mortality Data 1960-2005, National Center for Health Statistics, Centers for Disease Control and Prevention, 2008.

Cancer Death Rates* Among Men, US,1930-2005

Rate Per 100,000

Lung & bronchus

Stomach

Prostate

Colon & rectum

Pancreas

Leukemia

Liver

*Age-adjusted to the 2000 US standard population.

Source: US Mortality Data 1960-2005, US Mortality Volumes 1930-1959,

National Center for Health Statistics, Centers for Disease Control and Prevention, 2008.

Cancer Death Rates* Among Women, US,1930-2005

Rate Per 100,000

Lung & bronchus

Uterus

Breast

Stomach

Colon & rectum

Ovary

Pancreas

*Age-adjusted to the 2000 US standard population.

Source: US Mortality Data 1960-2005, US Mortality Volumes 1930-1959,

National Center for Health Statistics, Centers for Disease Control and Prevention, 2008.

Cancer Death Rates* by Race and Ethnicity, US, 2001-2005

*Per 100,000, age-adjusted to the 2000 US standard population.

^�Persons of Hispanic origin may be of any race.

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and

Population Sciences, National Cancer Institute, 2008.

Cancer Sites in Men for Which African American Death Rates* Exceed White Death Rates*, US, 2001-2005

Site

African American

White

Ratio of African American/White

All sites 313.0 230.7 1.4

Prostate 59.4 24.6 2.4

Larynx 4.8 2.1 2.3

Stomach 11.5 5.0 2.3

Myeloma 8.3 4.3 1.9

Oral cavity and pharynx 6.7 3.8 1.8

Small intestine 0.7 0.4 1.8

Liver and intrahepatic bile duct 10.3 6.7 1.5

Colon and rectum 31.8 22.1 1.4

Esophagus 9.8 7.8 1.3

Lung and bronchus 93.1 71.3 1.3

Pancreas 15.4 12.1 1.3

*Per 100,000, age-adjusted to the 2000 US standard population.

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and

Population Sciences, National Cancer Institute, 2008.

Cancer Sites in Women for Which African American Death Rates* Exceed White Death Rates*, US, 2001-2005

Site

African American

White

Ratio of African American/White

All sites 186.7 159.2 1.2

Stomach 5.5 2.5 2.2

Myeloma 6.0 2.8 2.1

Uterine cervix 4.7 2.3 2.0

Esophagus 2.8 1.6 1.8

Uterine corpus 7.1 3.9 1.8

Small intestine 0.5 0.3 1.7

Larynx 0.8 0.5 1.6

Colon and rectum 22.4 15.3 1.5

Pancreas 12.4 9.0 1.4

Breast 33.5 24.4 1.4

Gallbladder 1.0 0.8 1.3

Urinary bladder 2.8 2.2 1.3

Liver and intrahepatic bile duct 3.9 2.9 1.3

*Per 100,000, age-adjusted to the 2000 US standard population.

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and Population Sciences, National Cancer Institute, 2008.

Cancer Death Rates* by Sex and Race, US, 1975-2005

Rate Per 100,000

African American men

White men

African American women

White women

*Age-adjusted to the 2000 US standard population.

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and

Population Sciences, National Cancer Institute, 2008.

2009 Estimated US Cancer Cases*

Men
766,130

Women
713,220

Prostate 25%

Lung & bronchus 15%

Colon & rectum 10%

Urinary bladder 7%

Melanoma of skin 5%

Non-Hodgkin 5% lymphoma

Kidney & renal pelvis 5%

Leukemia 3%

Oral cavity 3%

Pancreas 3%

All Other Sites 19%

27% Breast

14% Lung & bronchus

10% Colon & rectum

6% Uterine corpus

4% Non-Hodgkin
lymphoma

4% Melanoma of skin

4% Thyroid

3% Kidney & renal pelvis

3% Ovary

3% Pancreas

22% All Other Sites

*Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder.

Source: American Cancer Society, 2009.

Cancer Incidence Rates* by Sex, US, 1975-2005

Rate Per 100,000

Men

Both Sexes

Women

*Age-adjusted to the 2000 US standard population and adjusted for delays in reporting.

Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database:

SEER Incidence Delay-adjusted Rates, 9 Registries, 1975-2005, National Cancer Institute, 2008.

Cancer Incidence Rates* Among Men, US, 1975-2005

Rate Per 100,000

Prostate

Lung & bronchus

Colon and rectum

Urinary bladder

Non-Hodgkin lymphoma

Melanoma of the skin

*Age-adjusted to the 2000 US standard population and adjusted for delays in reporting.

Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database:

SEER Incidence Delay-adjusted Rates, 9 Registries, 1975-2005, National Cancer Institute, 2008.

Cancer Incidence Rates* Among Women, US, 1975-2005

Rate Per 100,000

Breast

Colon and rectum

Lung & bronchus

Ovary

Uterine Corpus

Non-Hodgkin lymphoma

*Age-adjusted to the 2000 US standard population and adjusted for delays in reporting.

Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database:

SEER Incidence Delay-adjusted Rates, 9 Registries, 1975-2005, National Cancer Institute, 2008.

Cancer Incidence Rates* by Race and Ethnicity, 2001-2005

Rate Per 100,000

*Age-adjusted to the 2000 US standard population.

^�Person of Hispanic origin may be of any race.

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and

Population Sciences, National Cancer Institute, 2008.

Cancer Incidence Rates* by Sex and Race, US,1975-2005

Rate Per 100,000

African American men

White men

White women

African American women

*Age-adjusted to the 2000 US standard population.

Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database:

SEER Incidence Delay-adjusted Rates, 9 Registries, 1975-2005, National Cancer Institute, 2008.

Lifetime Probability of Developing Cancer, Men, 2003-2005*

Site

Risk

All sites^� 1 in 2

Prostate 1 in 6

Lung and bronchus 1 in 13

Colon and rectum 1 in 18

Urinary bladder^� 1 in 27

Melanoma^� 1 in 39

Non-Hodgkin lymphoma 1 in 45

Kidney 1 in 57

Leukemia 1 in 67

Oral Cavity 1 in 72

Stomach 1 in 90

* For those free of cancer at beginning of age interval.

� All Sites exclude basal and squamous cell skin cancers and in situ cancers except urinary bladder.

Source: DevCan: Probability of Developing or Dying of Cancer Software, Version 6.3.0 Statistical Research and Applications Branch, NCI, 2008. http://srab.cancer.gov/devcan

� Includes invasive and in situ cancer cases

� Statistic for white men.

Lifetime Probability of Developing Cancer, Women, US, 2003-2005*

Site

Risk

All sites^� 1 in 3

Breast 1 in 8

Lung & bronchus 1 in 16

Colon & rectum 1 in 20

Uterine corpus 1 in 40

Non-Hodgkin lymphoma 1 in 53

Urinary bladder^� 1 in 84

Melanoma^� 1 in 58

Ovary 1 in 72

Pancreas 1 in 75

Uterine cervix 1 in 145

* For those free of cancer at beginning of age interval.

� All Sites exclude basal and squamous cell skin cancers and in situ cancers except urinary bladder.

Source: DevCan: Probability of Developing or Dying of Cancer Software, Version 6.3.0 Statistical Research and Applications Branch, NCI, 2008. http://srab.cancer.gov/devcan

� Includes invasive and in situ cancer cases

� Statistic for white women.

Cancer Survival*(%) by Race,1996-2004

Site

White

American

African

Absolute

Difference

All Sites 68 58 10

Breast (female) 91 78 13

Colon 66 55 11

Esophagus 18 11 7

Leukemia 52 42 10

Non-Hodgkin lymphoma 66 58 8

Oral cavity 62 42 20

Prostate 99 96 3

Rectum 67 59 8

Urinary bladder 82 66 16

Uterine cervix 74 65 9

Uterine corpus 86 61 25

*5-year relative survival rates based on cancer patients diagnosed from 1996 to 2004 and followed through 2005.

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and

Population Sciences, National Cancer Institute, 2008.

Trends in Five-year Relative Survival (%)* Rates, US, 1975-2004

Site

1975-1977

1984-1986

1996-2004

All sites 50 54 66

Breast (female) 75 79 89

Colon 52 59 65

Leukemia 35 42 51

Lung and bronchus 13 13 16

Melanoma 82 87 92

Non-Hodgkin lymphoma 48 53 65

Ovary 37 40 46

Pancreas 3 3 5

Prostate 69 76 99

Rectum 49 57 67

Urinary bladder 74 78 81

*5-year relative survival rates based on follow up of patients through 2005.

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and

Population Sciences, National Cancer Institute, 2008.

Cancer Incidence & Death Rates* in Children 0-14 Years, 1975-2005

Rate Per 100,000

Incidence

Mortality

*Age-adjusted to the 2000 Standard population.

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and Population Sciences, National Cancer Institute, 2008.

Cancer Incidence Rates* in Children 0-14 Years by Sex, 2001-2005

Site Male Female Total

All sites 16.1 14.1 15.1

Leukemia 5.4 4.5 5.0

Acute Lymphocytic 4.3 3.6 3.9

Brain/ONS 3.4 3.1 3.2

Soft tissue 1.1 1.0 1.1

Non-Hodgkin lymphoma 1.2 0.6 0.9

Kidney and renal pelvis 0.8 0.8 0.8

Bone and Joint 0.7 0.7 0.7

Hodgkin lymphoma 0.7 0.4 0.5

*Per 100,000, age-adjusted to the 2000 US standard population.

ONS = Other nervous system

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and Population Sciences, National Cancer Institute, 2008.

Cancer Death Rates* in Children 0-14 Years by Sex, US, 2001-2005

Site Male Female Total

All sites 2.7 2.3 2.5

Leukemia 0.8 0.7 0.8

Acute Lymphocytic 0.4 0.3 0.4

Brain/ONS 0.8 0.7 0.7

Non-Hodgkin lymphoma 0.1 0.1 0.1

Soft tissue 0.1 0.1 0.1

Bone and Joint 0.1 0.1 0.1

Kidney and Renal pelvis 0.1 0.1 0.1

*Per 100,000, age-adjusted to the 2000 US standard population.

ONS = Other nervous system

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and Population Sciences, National Cancer Institute, 2008.

Trends in Cancer Survival by Age Group, Children 0-14 Years,1975-2004

Age

Year of
Diagnosis

5 - Year Relative Survival Rates *

0 - 4 Years

5 - 9 Years

10 - 14 Years

1975 - 1977
1996 - 2004

*5-year relative survival rates, based on follow up of patients through 2005.
Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and

Population Sciences, National Cancer Institute, 2008.

Tobacco Use in the US, 1900-2005

Per capita cigarette consumption

Male lung cancer death rate

Female lung cancer death rate

*Age-adjusted to 2000 US standard population.

Source: Death rates: US Mortality Data, 1960-2005, US Mortality Volumes, 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 2006. Cigarette consumption: US Department of Agriculture, 1900-2007.

Trends in Cigarette Smoking Prevalence* (%), by Sex, Adults 18 and Older, US, 1965-2007

Men

Women

*Redesign of survey in 1997 may affect trends.

Source: National Health Interview Survey, 1965-2007, National Center for Health Statistics, Centers for Disease Control and Prevention, 2008.

Current* Cigarette Smoking Prevalence (%) Among High School Students by Sex and Race/Ethnicity, US, 1991-2007

*Smoked cigarettes on one or more of the 30 days preceding the survey.
Source: Youth Risk Behavior Surveillance System, 1991, 1995, 1997, 1999, 2001, 2003, 2005, 2007 National Center for

Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2008.

Trends in Consumption of Five or More Recommended Vegetable and Fruit Servings for Cancer Prevention, Adults 18 and Older, US, 1994-2007

Note: Data from participating states and the District of Columbia were aggregated to represent the United States.

Source: Behavioral Risk Factor Surveillance System CD-ROM (1984-1995, 1996, 1998) and Public Use Data Tape (2000, 2003, 2005, 2007), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 1999, 2000, 2001, 2004, 2006, 2008.

Trends in Prevalence (%) of No Leisure-Time Physical Activity, by Educational Attainment, Adults 18 and Older, US, 1992-2007

Adults with less than a high school education

All adults

Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Educational attainment is for adults 25 and older.

Source: Behavioral Risk Factor Surveillance System CD-ROM (1984-1995, 1996, 1998) and Public Use Data Tape (2000, 2002, 2004, 2005, 2006, 2007), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 1999, 2000, 2001, 2003, 2005, 2006, 2007, 2008.

Trends in Prevalence (%) of High School Students Attending PE Class Daily, by Grade, US, 1991-2007

Source: Source: Youth Risk Behavior Surveillance System, 1991, 1995, 1997, 1999, 2001, 2003, 2005, 2007 National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2008.

Trends in Obesity* Prevalence (%), Children and Adolescents, by Age Group, US, 1971-2006

*Body mass index (BMI) at or above the sex-and age-specific 95^th percentile BMI cutoff points from the 2000 sex-specific BMI-for-age CDC Growth Charts. Note: Previous editions of Cancer Statistics used the term �overweight� to describe youth in this BMI category.

Source: National Health and Nutrition Examination Survey, 1971-1974, 1976-1980, 1988-1994, 1999-2002, National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, 2004. 2003-2006: Ogden CL, et al. High Body Mass Index for Age among US Children and Adolescents, 2003-2006. JAMA 2008; 299 (20): 2401-05.

Trends in Obesity* Prevalence (%), By Gender, Adults Aged 20 to 74, US, 1960-2006^�

*Obesity is defined as a body mass index of 30 kg/m²or greater. � Age adjusted to the 2000 US standard population. Source: National Health Examination Survey 1960-1962, National Health and Nutrition Examination Survey, 1971-1974, 1976-1980, 1988-1994, 1999-2002, National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, 2004. 2003-2004, 2005-2006: National Health and Nutrition Examination Survey Public Use Data Files, 2003-2004, 2005-2006, National Center for Health Statistics, Centers for Disease Control and Prevention, 2006, 2007.

Trends in Overweight* Prevalence (%), Adults 18 and Older, US, 1992-2007

1992

1995

1998

2007

Less than 50%

50 to 55%

More than 55%

State did not participate in survey

*Body mass index of 25.0 kg/m²or greater. Source: Behavioral Risk Factor Surveillance System, CD-ROM (1984-1995, 1998) and Public Use Data Tape (2004-2007), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 2000, 2005, 2007, 2008.

Screening Guidelines for the Early Detection of
Breast Cancer, American Cancer Society

Yearly mammograms are recommended starting at age 40.

A clinical breast exam should be part of a periodic health examination, about every 3 years for women in their 20s and 30s. Asymptomatic women aged 40 and older should continue to undergo a clinical breast exam, preferably annually*.

Beginning in their early 20s, women should be told about the benefits and limitations of breast-self examination. Women should know how their breasts normally feel and report any breast changes promptly to their health care providers.

__________

* Beginning at age 40 years, annual CBE should be performed prior to mammography

Mammogram Prevalence (%), by Educational Attainment and Health Insurance Status, Women 40 and Older, US, 1991-2006

All women 40 and older

Women with less than a high school education

Women with no health insurance

*A mammogram within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States.

Source: Behavior Risk Factor Surveillance System CD-ROM (1984-1995, 1996-1997, 1998, 1999) and Public Use Data Tape (2000, 2002, 2004, 2006), National Centers for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 1999, 2000, 2000, 2001, 2003, 2005, 2007.

Screening Guidelines for the Early Detection of
Cervical Cancer, American Cancer Society

�Screening should begin approximately three years after a women begins having vaginal intercourse, but no later than 21 years of age.

�Screening should be done every year with regular Pap tests or every two years using liquid-based tests.

�At or after age 30, women who have had three normal test results in a row may get screened every 2-3 years with cervical cytology (either conventional or liquid-based Pap test) alone, or every 3 years with a human papillomavirus DNA test plus cervical cytology.

�Women 70 and older who have had three or more consecutive Pap tests in the last ten years may choose to stop cervical cancer screening.

�Screening after a total hysterectomy (with removal of the cervix) is not necessary unless the surgery was done as a treatment for cervical cancer.

Trends in Recent* Pap Test Prevalence (%), by Educational Attainment and Health Insurance Status, Women 18 and Older, US, 1992-2006

All women 18 and older

Women with no health insurance

Women with less than a high school education

* A Pap test within the past three years. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Educational attainment is for women 25 and older.

Source: Behavior Risk Factor Surveillance System CD-ROM (1984-1995, 1996-1997, 1998, 1999) and Public Use Data Tape (2000, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Center for Disease Control and Prevention, 1997, 1999, 2000, 2000, 2001, 2003, 2005, 2007.

Screening Guidelines for the Early Detection of Colorectal Cancer and Adenomas, American Cancer Society 2008

People who are at moderate or high risk for colorectal cancer should talk with a doctor about a different testing schedule

Beginning at age 50, men and women should follow one of the following examination schedules:

A flexible sigmoidoscopy (FSIG) every five years

A colonoscopy every ten years

A double-contrast barium enema every five years

A Computerized Tomographic (CT) colonography every five years

A guaiac-based fecal occult blood test (FOBT) or a fecal immunochemical test (FIT) every year

A stool DNA test (interval uncertain)

Tests that detect adenomatous polyps and cancer

�Tests that primarily detect cancer

Trends in Recent* Fecal Occult Blood Test Prevalence (%), by Educational Attainment and Health Insurance Status, Adults 50 Years and Older, US, 1997-2006

*A fecal occult blood test within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States.

Source: Behavioral Risk Factor Surveillance System CD-ROM (1996-1997, 1999) and Public Use Data Tape (2001, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention and Prevention, 1999, 2000, 2002, 2003, 2005, 2007.

Trends in Recent* Flexible Sigmoidoscopy or Colonoscopy Prevalence (%), by Educational Attainment and Health Insurance Status, Adults 50 Years and Older, US, 1997-2006

*A flexible sigmoidoscopy or colonoscopy within the past ten years. Note: Data from participating states and the District of Columbia were aggregated to represent the United States.

Screening Guidelines for the Early Detection of
Prostate Cancer, American Cancer Society

Beginning at age 50, to men who have a life expectancy of at least 10 years, health care providers should discuss the potential benefits and limitations of prostate cancer early detection testing with men and offer the PSA blood test and the digital rectal examination.*

___________

* Information should be provided to men regarding the benefits and limitations of testing so that an informed decision concerning testing can be made with the clinician�s assistance.

Recent* Prostate-Specific Antigen (PSA) Test Prevalence (%), by Educational Attainment and Health Insurance Status, Men 50 Years and Older, US, 2001-2006

*A prostate-specific antigen (PSA) test within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States.

Source: Behavioral Risk Factor Surveillance System Public Use Data Tape (2001, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2002, 2003, 2005, 2007.

Recent* Digital Rectal Examination (DRE) Prevalence (%), by Educational Attainment and Health Insurance Status, Men 50 Years and Older, US, 2001-2006

*A digital rectal examination (DRE) within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States.

Sunburn* Prevalence (%) in the Past Year, Adults 18 and Older, US, 2004

*Reddening of any part of the skin for more than 12 hours. Note: The overall prevalence of sunburn among adult males is 46.4% and among females is 36.3%.

Source: Behavioral Risk Factor Surveillance System Public Use Data Tape , 2004. National Center for Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2005.

Ultraviolet Radiation Exposure Behaviors* Prevalence (%), Adults 18 and Older, US, 2005

*Proportion of respondents reporting always or often practicing the particular sun protection behavior on any warm sunny day. �Used an indoor tanning device, including a sunbed, sunlamp, or tanning booth at least once, in the past 12 months.

Source: National Health Interview Survey Public Use Data File 2005, National Center for Health Statistics, Centers for Disease Control and Prevention, 2006.

Thank you

Cancer Information

Programs & Services

ACS Events

About ACS

More ACS Sites

Set Your Preferences

Your Local Offices

Cancer Information

Programs & Services

ACS Events

About ACS

More ACS Sites